Twenty years ago, Dr Ronell Klingman (Bernstein) MD had the courage to venture outside the familiar boundaries of medical practice, and founded Integremed, a company aimed at merging medical expertise, innovation, and creativity. With the support of the WRITE team, colleagues, and a vast network of individuals, Integremed has become a beacon of excellence, renowned for its unparalleled medical expertise, research, quality and innovative spirit. We have been privileged to witness some of the greatest technological and pharmacological breakthroughs in medicine from targeted cancer therapies, the first artificial pancreas, malaria, and Ebola vaccines, and the CRISPR gene editing revolution. Integremed has also demonstrated the resilience to weather the storms of economic downturns, medical regulatory barriers, and the challenges of COVID-19 lockdowns amongst others. For over a decade, the Integremed team has operated in a fully virtual capacity with members located in various countries and cities united by a shared mission to continually excel as the WRITE specialists. We take immense pride in the fact that there is virtually no therapeutic area and very few key players in the pharma industry that Integremed has not touched. We are immensely proud of our team's compassion, commitment, and dedication to pushing the boundaries of innovation and creativity in specialized medical writing. As we look ahead to the next 20 years, we are excited to see what the future holds.
top of page
bottom of page